Amoéba S.A. (EPA:ALMIB)

France flag France · Delayed Price · Currency is EUR
1.030
-0.012 (-1.15%)
At close: Feb 27, 2026
13.69%
Market Cap 70.95M
Revenue (ttm) n/a
Net Income (ttm) -8.30M
Shares Out 68.89M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 335,291
Average Volume 237,648
Open 1.050
Previous Close 1.042
Day's Range 1.004 - 1.050
52-Week Range 0.748 - 1.444
Beta 0.01
RSI 64.85
Earnings Date Mar 27, 2026

About Amoéba

Amoéba S.A. develops biological products and services for the treatment of microbiological risk in the sectors of water, health, and plant protection in France. The company has developed technology to treat water, surfaces, and chronic wounds that uses the natural biocidal capacity of the living amoeba Willaertia magna C2c Maky; and agriculture biocontrol technology for the treatment of phytopathogenic microorganisms using the lysed. Amoéba S.A. was incorporated in 2010 and is based in Chassieu, France. [Read more]

Sector Materials
Founded 2010
Employees 20
Stock Exchange Euronext Paris
Ticker Symbol ALMIB
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.